Stay updated on PRS-343 HER2+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.

Latest updates to the PRS-343 HER2+ Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3. This indicates a minor backend/content-management update without changes to the study details.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2. This reflects a backend/template update for the ClinicalTrials.gov study page.SummaryDifference0.1%

- Check26 days agoChange DetectedDeleted a large set of keywords and labels that describe the study's target, mechanism, and design (HER2, CD137/4-1BB, PRS-343, dose escalation, expansion cohorts, interventional model, arms and interventions). Related disease context and location references were also removed, reducing the specificity of the trial description.SummaryDifference17%

- Check33 days agoChange DetectedRecruitment status is changed to not enrolling, indicating participants are no longer being sought. New help sections and navigation links (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment heading formatting was updated along with a revision from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check40 days agoChange DetectedThe page revision was updated to v3.5.5. This appears to be a metadata/version update and does not change the study details or core content.SummaryDifference0.1%

- Check62 days agoChange DetectedA newer site revision tag, Revision: v3.5.4, has been added, replacing the previous v3.5.3. This reflects a minor site release or update to the page’s metadata rather than a substantive change to content visible to users.SummaryDifference0.1%

Stay in the know with updates to PRS-343 HER2+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.